Category: Dissemination

12

12. Gonzalez R, Mombo-Ngoma G, Ouedraogo S, et al. Intermittent Preventive Treatment of Malaria in Pregnancy with Mefloquine in HIV-Negative Women: A Multicentre Randomized Controlled Trial. PLoS Med. 2014; 11:e1001733.

28

28. Agnandji ST, Huttner A, Zinser ME, et al. Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe. The New England journal of medicine. 2016; 374:1647-60.

27

27. Castillo P, Ussene E, Ismail MR, et al. Pathological Methods Applied to the Investigation of Causes of Death in Developing Countries: Minimally Invasive Autopsy Approach. PloS one. 2015; 10:e0132057.

29

29. Kayentao K, Doumbo OK, Penali LK, et al. Pyronaridine-artesunate granules versus artemether-lumefantrine crushed tablets in children with Plasmodium falciparum malaria: a randomized controlled trial. Malaria journal. 2012; 11:364.

26

26. Sigauque B, Vubil D, Sozinho A, et al. Haemophilus influenzae type b disease among children in rural Mozambique: impact of vaccine introduction. The Journal of pediatrics. 2013; 163:S19-24.

25

25. Naniche D, Bardaji A, Lahuerta M, et al. Impact of maternal human immunodeficiency virus infection on birth outcomes and infant survival in rural Mozambique. Am J Trop Med Hyg. 2009; 80:870-6.

30

30. Mombo-Ngoma G, Supan C, Dal-Bianco MP, et al. Phase I randomized dose-ascending placebo-controlled trials of ferroquine–a candidate anti-malarial drug–in adults with asymptomatic Plasmodium falciparum infection. Malaria journal. 2011; 10:53.

31

31. Ramharter M, Kurth F, Schreier AC, et al. Fixed-dose pyronaridine-artesunate combination for treatment of uncomplicated falciparum malaria in pediatric patients in Gabon. The Journal of infectious diseases. 2008; 198:911- 9.

32

32. Desai M, Gutman J, L’Lanziva A, et al. Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine- pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial. Lancet. 2015; 386:2507-19.

24

24. Gonzalez R, Augusto OJ, Munguambe K, et al. HIV Incidence and Spatial Clustering in a Rural Area of Southern Mozambique. PloS one. 2015; 10:e0132053.

33

33. Kakuru A, Jagannathan P, Muhindo MK, et al. Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy. N Engl J Med. 2016; 374:928-39.

23

23. Aponte JJ, Schellenberg D, Egan A, et al. Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials. Lancet (London, England). 2009; 374:1533-42..

36

36. Pekyi D, Ampromfi AA, Tinto H, et al. Four Artemisinin-Based Treatments in African Pregnant Women with Malaria. N Engl J Med. 2016; 374:913-27.

10

10. Zou G. A modified poisson regression approach to prospective studies with binary data. American journal of epidemiology. 2004; 159:702-6.

9

9. WHO. Consolidated Guidelines on The Use of Antiretroviral Drugs for Treating And Preventing HIV infection. WHO. 2013.

16

16. Gonzalez R, Munguambe K, Aponte J, et al. High HIV prevalence in a southern semi-rural area of Mozambique: a community-based survey. HIV Med. 2012.

15

15. Mombo-Ngoma G, Mackanga JR, Gonzalez R, et al. Young adolescent girls are at high risk for adverse pregnancy outcomes in sub-Saharan Africa: an observational multicountry study. BMJ open. 2016; 6:e011783.

14

14. Bouyou-Akotet MK, Mawili-Mboumba DP and Kombila M. Antenatal care visit attendance, intermittent preventive treatment and bed net use during pregnancy in Gabon. BMC pregnancy and childbirth. 2013; 13:52.

18

18. Caron M, Lekana-Douki SE, Makuwa M, et al. Prevalence, genetic diversity and antiretroviral drugs resistance-associated mutations among untreated HIV-1-infected pregnant women in Gabon, central Africa. BMC infectious diseases. 2012; 12:64.

17

17. Manego RZ, Mombo-Ngoma G, Witte M, et al. Demography, maternal health and the epidemiology of malaria and other major infectious diseases in the rural department Tsamba-Magotsi, Ngounie Province, in central African Gabon. BMC Public Health. 2017; 17:130.

21

21. Ministère-de-la-Santé-et-de-la-Prévoyance-sociale-Gabon. Rapport National sur la Réponse au VIH/SIDA 2014. 2015

20

UNAIDS. Mozambique country Fact sheet. 2016:

19

19. Lahuerta M, Aparicio E, Bardaji A, et al. Rapid spread and genetic diversification of HIV type 1 subtype C in a rural area of southern Mozambique. AIDS research and human retroviruses. 2008; 24:327-35.

34

34. Rijken MJ, McGready R, Boel ME, et al. Dihydroartemisinin-piperaquine rescue treatment of multidrug- resistant Plasmodium falciparum malaria in pregnancy: a preliminary report. Am J Trop Med Hyg. 2008; 78:543-5.

22

22. Alonso PL, Sacarlal J, Aponte JJ, et al. Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet. 2004; 364:1411-20.

35

35. Poespoprodjo JR, Fobia W, Kenangalem E, et al. Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy. PloS one. 2014; 9:e84976.

13

13. Menendez C, Bardaji A, Sigauque B, et al. A randomized placebo-controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinic. PloS one. 2008; 3:e1934.

11

11. Zou GY and Donner A. Extension of the modified Poisson regression model to prospective studies with correlated binary data. Statistical methods in medical research. 2013; 22:661-70.

37

37. Desai M, Gutman J, L’Lanziva A, et al. Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine- pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial. Lancet. 2015.